Observational Study
Copyright ©The Author(s) 2021.
World J Psychiatr. Nov 19, 2021; 11(11): 1116-1128
Published online Nov 19, 2021. doi: 10.5498/wjp.v11.i11.1116
Table 1 Univariate comparisons of demographic and clinical features by empirically-derived clusters (n = 105), mean ± SD

Total
Simple pharmacy,short-term antidepressants use (SA, n = 19)
Simple pharmacy,long-term antidepressants use (LA, n = 33)
Complex pharmacy,long-term antidepressants and sedatives use (LAS, n = 34)
Complex pharmacy,long-term antidepressants, sedatives and augmentation use (LASA, n = 19)
P value for univariate omnibus test
Demographic and general clinical data
Age (yr)51.5 (13.2)42.6 (14.4)50.6 (15.2)54.9 (9.1)56.5 (10.3)0.02
Age of onset (yr)44.5 (13.6)36.3 (14.4)43.2 (15.3)48.6 (10.0)49.6 (11.0)0.01
Female, n (%)80 (75.5)15 (78.9)24 (72.7)27 (79.4)13 (68.4)0.79
Comorbid anxiety disorder, n (%)22 (20.8)6 (31.6)9 (27.3)4 (11.8)3 (15.8)0.25
Number of comorbid physical diseases0.7 (1.3)0.5 (1.2)0.7 (1.4)1.1 (1.5)0.6 (1.2)0.39
Follow-up duration after 2-yr of disease onset (yr)3.7 (3.5)3.2 (3.2)3.4 (3.1)3.7 (3.2)3.8 (3.9)0.91
Psychotropic loads
Antidepressant load (defined daily dose/month)34.5 (18.4)13.3 (7.2)32.1 (13.1)42.8 (17.3)44.8 (17.7)< 0.001
Sedative load (equivalent dose/month)57.3 (56.8)8.1 (10.8)18.5 (20.9)91.9 (45.4)112.0 (56.7)< 0.001
Augmentation load (defined daily dose/month)1.2 (2.7)0.1 (0.5)0.3 (0.6)0.3 (1.0)5.3 (4.0)< 0.001
Clinical feature within 2-yr of disease onset
Number of antidepressants use1.7 (0.9)1.3 (0.6)1.6 (0.8)1.9 (1.1)1.9 (0.9)0.07
Number of antidepressants use with adequate dosage and duration1.5 (0.9)1.1 (0.5)1.3 (0.8)1.7 (1.2)1.8 (0.8)0.04
Visits of psychiatric outpatient service17.3 (10.7)10.6 (5.8)15.5 (5.1)20.2 (10.6)21.8 (17.1)0.002
Frequencies of psychiatric admission 0.2 (0.5)0.1 (0.3)0.2 (0.4)0.1 (0.3)0.7 (0.8)< 0.001
Clinical feature beyond 2-yr of disease onset
Visits of psychiatric outpatient service31.1 (66.7)9.7 (10.3)20.2 (24.7)41.4 (91.6)42.6 (78.4)0.22
Frequencies of psychiatric admission0.8 (0.5)0.0 (0.0)0.1 (0.4)0.1 (0.7)0.0 (0.0)0.71
Severity of depression in the recruitment11.5 (0.9)0.6 (1.0)0.9 (1.2)1.2 (1.3)1.7 (1.2)0.02
Table 2 Multivariable analyses for the comparisons of clinical features by empirically-derived clusters (n = 105)

Simple pharmacy, short-term antidepressants use (SA, n = 19)
Simple pharmacy, long-term antidepressants use (LA, n = 33)
Complex pharmacy, long-term antidepressants and sedatives use (LAS, n = 34)
Complex pharmacy, long-term antidepressants, sedatives and augmentation use (LASA, n = 19)
P value for pos-hoc comparison using multivariable regression test
IRR (95%CI)IRR (95%CI)IRR (95%CI)IRR (95%CI)
Clinical feature within 2-yr of disease onset1
Number of antidepressants use0.57 (0.32-0.82)0.74 (0.52-0.97)0.94 (0.66-1.23)0.96 (0.61-1.31)
Number of antidepressants use with adequate dosage and duration0.50 (0.26-0.73)0.64 (0.44-0.85)0.87 (0.59-1.15)0.95 (0.60-1.31)SA < LAS (P = 0.04); SA < LASA (P = 0.03)
Visits of psychiatric outpatient service4.76 (4.04-5.47)7.46 (6.75-8.17)10.34 (9.37-11.30)11.37 (10.15-12.58)SA < LA (P < 0.001); SA < LAS (P < 0.001); SA < LASA (P < 0.001); LA < LAS (P < 0.001); LA < LASA (P < 0.001)
Frequencies of psychiatric admission 0.03 (-0.02-0.08)0.05 (-0.002-0.10)0.03 (-0.01-0.08)0.24 (0.04-0.44)SA < LASA (P = 0.01); LA < LASA (P = 0.004); LAS < LASA (P = 0.001)
Clinical feature beyond 2-yr of disease onset
Visits of psychiatric outpatient service23.03 (2.58-3.49)5.81 (5.34-6.30)10.21 (9.49-10.93)10.86 (9.98-11.74)SA < LAS (P < 0.001); SA < LA (P < 0.001); SA < LASA (P < 0.001); LA < LAS (P < 0.001); LA < LASA (P < 0.001)
Frequencies of psychiatric admission3----
EMM (95%CI)EMM (95%CI)EMM (95%CI)EMM (95%CI)
Severity of depression in the recruitment40.58 (0.23-0.93)0.90 (0.54-1.25)1.66 (1.10-2.22)2.20 (1.37-3.30)SA < LAS (P = 0.002); SA < LASA (P < 0.001); LA < LAS (P = 0.02); LA < LASA (P = 0.001)